Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Rizzolio

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
Advanced Healthcare Materials|February 9, 2024
Human Omental Mature Adipocytes used as Paclitaxel Reservoir for Cell-Based Therapy in Ovarian CancerPacome K Andele, Stefano Palazzolo, Giuseppe Corona, et al.
Journal of Cellular Physiology|March 25, 2014
Metabolomics biomarkers of frailty in elderly breast cancer patientsGiuseppe Corona, Jerry Polesel, Lucia Fratino, et al.
RSC Advances|August 23, 2024
Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery applicationKanwal Asif, Md Mahbubur Rahman, Andrea Augusto Sfriso, et al.
Journal of Biomolecular Structure & Dynamics|May 26, 2020
Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening studyVibhu Jha, Salvatore Galati, Valerio Volpi, et al.
European Journal of Human Genetics : EJHG|July 29, 2004
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28Francesca Rossetti, Flavio Rizzolio, Tiziano Pramparo, et al.
Dalton Transactions (Cambridge, England : 2003)|July 8, 2022
Cationic palladium(II)-indenyl complexes bearing phosphines as ancillary ligands: synthesis, and study of indenyl amination and anticancer activityEnrica Bortolamiol, Francesco Fama, Ziyun Zhang, et al.
Bioorganic & Medicinal Chemistry|May 24, 2014
Identification and characterization of a new reversible MAGL inhibitorTiziano Tuccinardi, Carlotta Granchi, Flavio Rizzolio, et al.
Journal of Advanced Research|March 23, 2023
Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapiesKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 23, 2017
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitorsCarlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Nanomedicine (London, England)|October 1, 2015
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicinGiuseppe Toffoli, Mohamad Hadla, Giuseppe Corona, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
Advanced Healthcare Materials|February 9, 2024
Human Omental Mature Adipocytes used as Paclitaxel Reservoir for Cell-Based Therapy in Ovarian CancerPacome K Andele, Stefano Palazzolo, Giuseppe Corona, et al.
Journal of Cellular Physiology|March 25, 2014
Metabolomics biomarkers of frailty in elderly breast cancer patientsGiuseppe Corona, Jerry Polesel, Lucia Fratino, et al.
RSC Advances|August 23, 2024
Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery applicationKanwal Asif, Md Mahbubur Rahman, Andrea Augusto Sfriso, et al.
Journal of Biomolecular Structure & Dynamics|May 26, 2020
Discovery of a new ATP-citrate lyase (ACLY) inhibitor identified by a pharmacophore-based virtual screening studyVibhu Jha, Salvatore Galati, Valerio Volpi, et al.
European Journal of Human Genetics : EJHG|July 29, 2004
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28Francesca Rossetti, Flavio Rizzolio, Tiziano Pramparo, et al.
Dalton Transactions (Cambridge, England : 2003)|July 8, 2022
Cationic palladium(II)-indenyl complexes bearing phosphines as ancillary ligands: synthesis, and study of indenyl amination and anticancer activityEnrica Bortolamiol, Francesco Fama, Ziyun Zhang, et al.
Bioorganic & Medicinal Chemistry|May 24, 2014
Identification and characterization of a new reversible MAGL inhibitorTiziano Tuccinardi, Carlotta Granchi, Flavio Rizzolio, et al.
Journal of Advanced Research|March 23, 2023
Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapiesKanwal Asif, Muhammad Adeel, Md Mahbubur Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 23, 2017
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitorsCarlotta Granchi, Isabella Caligiuri, Eleonora Bertelli, et al.
Nanomedicine (London, England)|October 1, 2015
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicinGiuseppe Toffoli, Mohamad Hadla, Giuseppe Corona, et al.
Pageof 16